Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG 3506 (STEEL).

Authors

Edwin Posadas

Edwin Melencio Posadas

Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA

Edwin Melencio Posadas , Hiram Alberto Gay , Joseph P Rodgers , Todd Matthew Morgan , Ying Xiao , James B. Yu , Jeff M. Michalski , Myriam Bouchard , Neil B Desai , Ryan Funk , Thomas Boike , Donald James Jurgens , Anthony C. Wong , Xinglei Shen , Lloyd T Miyawaki , Christopher S Bland , John C Hairston , Howard M. Sandler , Stephanie L Pugh , Felix Y Feng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03809000

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 131)

DOI

10.1200/JCO.2024.42.4_suppl.131

Abstract #

131

Poster Bd #

F2

Abstract Disclosures